Evidence map›Paper›PMID 34474613›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

Arachnoid membrane as a source of sphingosine-1-phosphate that regulates mouse middle cerebral artery tone.

Francesc Jiménez-Altayó, Julia Marzi, María Galan, Ana Paula Dantas, Marisa Ortega, Santiago Rojas, Gustavo Egea, Katja Schenke-Layland, Elena Jiménez-Xarrié, Anna M Planas

Open access · greenAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Francesc Jiménez-AltayóDepartament de Farmacologia, de Terapèutica i de Toxicologia, Institut de Neurociències, Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0002-9034-2041
Julia MarziDepartment of Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.ORCID 0000-0003-1545-5430
María GalanInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 16689Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona, Spain.
Ana Paula DantasInstitut Clínic Del Tòrax, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Marisa OrtegaUnit of Human Anatomy and Embriology, Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Santiago RojasUnit of Human Anatomy and Embriology, Department of Morphological Sciences, Faculty of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Gustavo EgeaDepartment of Biomedical Sciences, University of Barcelona School of Medicine and Health Sciences, Barcelona, Spain; IDIBAPS-University of Barcelona, Barcelona, Spain.
Katja Schenke-LaylandDepartment of Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.
Elena Jiménez-XarriéStroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), Barcelona, Spain.
Anna M PlanasDepartment of Brain Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain; Area of Neurosciences, IDIBAPS, Barcelona, Spain.ORCID 0000-0002-6147-1880
Universitat Autònoma de Barcelona · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital de Sant Pau · ESNatural and Medical Sciences Institute · DEConsejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence indicates that perivascular tissue is critical to modulate vessel function. We hypothesized that the arachnoid membrane surrounding middle cerebral artery (MCA) regulates its function via sphingosine-1-phosphate (S1P)-induced vasoconstriction. The MCA from 3- to 9-month-old male and female wild-type (Oncine France 1 and C57BL/6) mice and sphingosine kinase 2 knockout (SphK2-/-) mice in the C57BL/6 background was mounted in pressure myographs with and without arachnoid membrane. Raman microspectroscopy and imaging were used for in situ detection of S1P. The presence of arachnoid tissue was associated with reduced external and lumen MCA diameters, and with an increase in basal tone regardless of sex and strain background. Strong S1P-positive signals were detected in the arachnoid surrounding the MCA wall in both mice models, as well as in a human post-mortem specimen. Selective S1P receptor 3 antagonist TY 52156 markedly reduced both MCA vasoconstriction induced by exogenous S1P and arachnoid-dependent basal tone increase. Compared to 3-month-old mice, the arachnoid-mediated contractile influence persisted in 9-month-old mice despite a decline in arachnoid S1P deposits. Genetic deletion of SphK2 decreased arachnoid S1P content and vasoconstriction. This is the first experimental evidence that arachnoid membrane regulates the MCA tone mediated by S1P.

Indexed as

Signal TransductionVasoconstrictionAnimalsArachnoidFemaleHydrazonesLysophospholipidsMaleMiceMice, KnockoutMiddle Cerebral ArteryPhosphotransferases (Alcohol Group Acceptor)SphingosineSphingosine-1-Phosphate ReceptorsSphingosine Kinase1-(4-chlorophenylhydrazono)-1-(4-chlorophenylamino)-3,3-dimethyl-2-butanoneHydrazonesLysophospholipidsPhosphotransferases (Alcohol Group Acceptor)S1pr3 protein, mouseSphingosinesphingosine 1-phosphateSphingosine-1-Phosphate ReceptorsSphingosine Kinasesphingosine kinase 2, mouseArachnoid membranecerebral artery functioncerebral blood flowmyogenic tonesphingosine-1-phosphate

Identifiers

PMID34474613
PMCPMC8721773
OpenAlexW3197890364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.